Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

NCT06514534

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Nantes, France
View Trial Details
Recruiting

Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

NCT03188874

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Klinikum Mittelbaden Baden-Baden, Baden-Wurttemberg, Germany
  • Universtitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Klinikum Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany
  • Diakonie-Klinikum Schwäbisch Hall, Baden-Wurttemberg, Germany
View all 60 locations
View Trial Details
Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

NCT06247787

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

Asciminib RMP Study

NCT05943522

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Anyang-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Uijeongbu-si, Gyeonggi-do, South Korea
View all 17 locations
View Trial Details
Recruiting

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

NCT05294731

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Chao Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
View all 29 locations
View Trial Details

Related conditions